Pharma Patent Cliff Intelligence for Investors, Pharma Strategy & BD
LOE is the trigger - pharma revenue replacement is the decision. I’m building an intelligence platform that helps teams act early by mapping three replacement paths - indication expansion, next-asset readiness, and M&A/licensing - and translating them into scenarios for who wins, when competition arrives, and how far price erodes.
13+ years across EHR/device integration, medical devices, and enterprise commercialization - now building patent cliff intelligence grounded in real-world execution.
Early access is a short form + optional 20-min feedback call
What I am building: Runway Replacement Scenarios
Most LOE analysis stops at patent expiry. This platform connects LOE pressure + trial momentum to produce decision-ready replacement scenarios with timing, confidence, and “what to watch next".
-
Runway Radar: LOE pressure + “at-risk revenue” view with scenario ranges
-
Pipeline & Indication Signals: trial activity that predicts expansions and next-drug trajectories
-
Replacement Paths: internal vs external options (build/partner/buy) + credible M&A/licensing candidates
Investors
Cliff risk + replacement credibility + timing
Pharma Strategy
Portfolio gap mapping + defend vs acquire decisions
BD
Target prioritization + urgency signals + partnering rationale
Services
Runway & Replacement Intelligence
-
scenario briefs: best/base/worst runway + replacement paths
-
trial driven indication + pipeline momentum readouts
-
target shortlist: partner/buy candidates + watchlist triggers
EHR + Medical Device Integration (Interoperability SME)
-
integration strategy + implementation readiness (EHR + device data)
-
smart pump/device integration programs
-
workflow alignment, testing, training, go-live support
Commercial Operating Systems (GTM + Finance Alignment)
-
pipeline truth + forecasting
-
renewals/expansion motions
-
commissions process + reconciliation discipline